Getinge AB
STO:GETI B
Getinge AB
STO:GETI B
Price:
203.5
SEK
-0.1%
Market Cap:
kr55.4B
Relative Value
The Relative Value of one
GETI B
stock under the Base Case scenario is
230.82
SEK.
Compared to the current market price of 203.5 SEK,
Getinge AB
is
Undervalued by 12%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GETI B
Relative Value
Base Case
230.82
SEK
Undervaluation 12%
Multiples Across Competitors
GETI B Competitors Multiples
Getinge AB Competitors
Getinge AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Getinge AB
STO:GETI B
|
55.3B SEK | 1.6 | 24.5 | 9.5 | 14.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.1B USD | 4.3 | 29.1 | 16.5 | 22.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.1B USD | 17.2 | 60.5 | 46.1 | 55.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
139.2B USD | 5.6 | 43.1 | 21.9 | 26.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.6B USD | 3.8 | 27.9 | 15.6 | 22.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.9B USD | 5.9 | 41.1 | 24.4 | 33.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.3B USD | 2.7 | 35.2 | 12.9 | 21.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR | 2 | 22 | 12.5 | 17.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51B USD | 11.9 | 48.3 | 34.5 | 38.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 7.8 | 33.6 | 23.9 | 26.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
38.3B USD | 7.2 | 26.1 | 18.4 | 20.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
